Literature DB >> 19713711

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: biochemical markers.

Dermot O'Toole1, Ashley Grossman, David Gross, Gianfranco Delle Fave, Jaroslava Barkmanova, Juan O'Connor, Ulrich-Frank Pape, Ursula Plöckinger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19713711     DOI： 10.1159/000225948

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN： 0028-3835            Impact factor:   4.914


× No keyword cloud information.
  58 in total

Review 1.  Contemporary management of nonfunctioning pancreatic neuroendocrine tumors.

Authors:  Rebecca M Minter; Diane M Simeone
Journal:  J Gastrointest Surg       Date:  2011-10-19       Impact factor: 3.452

2.  The use of targeted therapies in pancreatic neuroendocrine tumours: patient assessment, treatment administration, and management of adverse events.

Authors:  Meredith Cummins; Nick Pavlakis
Journal:  Ther Adv Med Oncol       Date:  2013-09       Impact factor: 8.168

Review 3.  Endocrine Tumors Causing Arterial Hypertension: Pathophysiological Mechanisms and Clinical Implications.

Authors:  Agata Buonacera; Benedetta Stancanelli; Lorenzo Malatino
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-04-12

Review 4.  The extended granin family: structure, function, and biomedical implications.

Authors:  Alessandro Bartolomucci; Roberta Possenti; Sushil K Mahata; Reiner Fischer-Colbrie; Y Peng Loh; Stephen R J Salton
Journal:  Endocr Rev       Date:  2011-08-23       Impact factor: 19.871

Review 5.  Minireview: miRomics in endocrinology: a novel approach for modeling endocrine diseases.

Authors:  Péter M Szabó; Henriett Butz; Péter Igaz; Károly Rácz; László Hunyady; Attila Patócs
Journal:  Mol Endocrinol       Date:  2013-01-24

6.  Defining predictors for long progression-free survival after radioembolisation of hepatic metastases of neuroendocrine origin.

Authors:  Wieland H Sommer; Felix Ceelen; Xabier García-Albéniz; Philipp M Paprottka; Christoph J Auernhammer; Marco Armbruster; Konstantin Nikolaou; Alexander R Haug; Maximilian F Reiser; Daniel Theisen
Journal:  Eur Radiol       Date:  2013-06-28       Impact factor: 5.315

7.  Biochemical prognostic indicators for pancreatic neuroendocrine tumors and small bowel neuroendocrine tumors.

Authors:  Christine S Landry; Keith Cavaness; Scott Celinski; John Preskitt
Journal:  Gland Surg       Date:  2014-11

Review 8.  Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances.

Authors:  Tetsuhide Ito; Hisato Igarashi; Robert T Jensen
Journal:  Best Pract Res Clin Gastroenterol       Date:  2012-12       Impact factor: 3.043

9.  Differentiation of small bowel and pancreatic neuroendocrine tumors by gene-expression profiling.

Authors:  Jennifer C Carr; Erin A Boese; Philip M Spanheimer; Fadi S Dahdaleh; Molly Martin; Daniel Calva; Blanca Schafer; David M Thole; Terry Braun; Thomas M O'Dorisio; M Sue O'Dorisio; James R Howe
Journal:  Surgery       Date:  2012-12       Impact factor: 3.982

10.  Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors.

Authors:  L Bodei; M Kidd; I M Modlin; S Severi; I Drozdov; S Nicolini; D J Kwekkeboom; E P Krenning; R P Baum; G Paganelli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-11-23       Impact factor: 9.236
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.